Follow us:  

Department of Oncology

Last news
How lipid metabolism modulates tumor-associated macrophages to establish an immunosuppressive...
New research into membrane dynamics reveals how lipids derived from cancer cells can skew macrophages towards an immunosuppressive phenotype, via a manipulation of the lipid composition within the ER membrane.
Combined targeting of key pathways leads to optimal anti-cancer effects in breast-to-brain...
CSF1R inhibition is initially effective in treating preclinical models of breast-to-brain metastasis, but adaptive resistance can emerge via CSF2-STAT5 signalling. A new strategy, combining blockade of CSF1R and CSF2/STAT5 signaling offers a solution.
Yu-Ming Chuang/Ho Lab awarded GSSA (Taiwan)
Award to support research into metabolic regulation in metastasis and T cell exhaustion.
Une nouvelle administratrice pour la FBM
Depuis le 1er septembre 2021, Sylvie Traimond est la nouvelle administratrice de la Faculté de biologie et de médecine (FBM). Elle succède à Philippe Mathis, qui a occupé ce poste pendant 18 ans.
WE ARE...
- The fundamental & translational research community of the Department of oncology UNIL CHUV
- Home to the Ludwig Institute for Cancer Research Lausanne branch
- A collective of over 20 research labs at the University of Lausanne and the Lausanne University Hospital & 5 affiliated research labs at EPFL and the University of Geneva.
- A pole of excellence in the training and mentoring of the next generation of scientists and clinicians in oncology.
- A founding member of the Swiss Cancer Center Léman
Ch. des Boveresses 155 - CH-1066 Epalinges
Switzerland
Tel. +41 21 692 59 92
Fax +41 21 692 59 95
Ludwig Cancer Research Université de Lausanne Centre Hospitalier Universitaire Vaudois (CHUV)